Johnson & Johnson (J&J) and subsidiary DePuy reached a $120 million settlement agreement to resolve allegations that the company unlawfully promoted two metal-on-metal hip implant devices.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,